Jim Snyder

[Jim Snyder @JimSnyderDO]

@Lifeiskitsch You Definitely Will!!!

[St_Molly_AgentofChaos @Lifeiskitsch]

I better see your face on my screen tomorrow for #Head2Hill2021, @JimSnyderDO. @HenryFordNeuro #BTAM #BTSM

[Henry Ford Neuroscience @HenryFordNeuro]

Happy Laboratory Professionals Week to the Hermelin Brain Tumor Center Team! It is because of your efforts and passion that we continue to move forward towards new and exciting treatments! #labweek2021 @HenryFordNews @SteveKalkanisMD @JimSnyderDO

[Beans 4 Brains @GOCBeans4Brains]

**WORK IN PROGRESS** Getting ready to GO GRAY IN MAY! #HBTCStrong #Beans4Brains #CoffeeLovers

[Jim Snyder @JimSnyderDO]

@Lifeiskitsch Thanks for sharing @Lifeiskitsch —this is a move in the right direction from a classification perspective. I agree with you, it may be harder to connect the dots across criteria changes. Hopefully this will make diagnoses more accurate and clinically relevant.

[Jim Snyder @JimSnyderDO]

Proud to support #HFTCDetroit — Honored to be a part of team #HBTCstrong and @HenryFordNeuro —Thankful for the brain and spine tumor community and #HFTC who Inspire me and so many more

[Henry Ford Neuroscience @HenryFordNeuro]

Rise and shine! We are live for the Detroit Virtual 5K @HeadfortheCure @TobiasWalbertMD @JimSnyderDO @AdamMRobinMD @IanLeeMD @Nestelynn_Gay https://t.co/vfPoj9RC01

[Henry Ford Neuroscience @HenryFordNeuro]

Rise and shine! We are live for the Detroit Virtual 5K @HeadfortheCure @TobiasWalbertMD @JimSnyderDO @AdamMRobinMD @IanLeeMD @Nestelynn_Gay https://t.co/vfPoj9RC01

[Jim Snyder @JimSnyderDO]

@fschmnn @Lifeiskitsch @walkbald @HenryFordNeuro It’s complicated. Traditionally, we named brain tumors by how they look under a microscope. More recently, we use the genetics of the tumor (1p19q) as the critical factor in naming the tumor subtype. Some unofficially describe a tumor based on how it behaves too

[Jim Snyder @JimSnyderDO]

@AkalStation @Lifeiskitsch @HenryFordNeuro @AkalStation yes, they are typically molecularly different. Sometimes a low grade to high grade GBM is called a secondary GBM. Often, IDH is the molecular feature of interest in this consideration.

[Jim Snyder @JimSnyderDO]

@Lifeiskitsch @HenryFordNeuro You are most certainly on the right track! (We can still talk about it if you like). @Lifeiskitsch you are doing great things in brain tumor advocacy—raising awareness and providing a voice for many.

[Jim Snyder @JimSnyderDO]

@Lifeiskitsch @Sabine_NJ @HenryFordNeuro Hi @Lifeiskitsch and @Sabine_NJ I have not seen this used yet, but it seems like a valuable tool that may be informative for clinic care, tracking progress during recovery and research. Thanks for sharing!

[Henry Ford Neuroscience @HenryFordNeuro]

#Optune is an innovative step forward for those faced with a brain tumor diagnosis. Alongside the great care by our
@HenryFordNews of physician @JimSnyderDO we offer patients cutting edge treatments for #Glioblastoma @NeuroOnc @JNeurooncol @CNS_Update https://t.co/T595es9g3p

[Henry Ford Neuroscience @HenryFordNeuro]

Innovations and Teamwork help our #GBM patients become survivors at #HBTCStrong. Thanks to the technical skills of @IanLeeMD @JimSnyderDO and @SteveKalkanisMD we are dedicated to improving the lives of brain cancer patients. @CNS_Update @Novocure
https://t.co/uY8Knw8han

[Jim Snyder @JimSnyderDO]

Our search for a liquid biopsy solution for #braintumors and other neuro-oncology conditions has been absolutely fascinating and more rewarding than I ever thought. Thanks for tuning in to our #research.

[Henry Ford Innovations @HF_Innovations]

Innovation Alert!🚨
HFHS innovators are developing a liquid biopsy that can be used to help detect brain cancer. Instead of frequent MRIs, patients can have their blood drawn to look for tumor presence and change in tumor behavior with the hope to refine the patient experience.

[Henry Ford Neuroscience @HenryFordNeuro]

Thanks for listening in on @TobiasWalbertMD talk about our trial of #fSRS in #Avastin ‑resistant high‑grade #glioma at Tumor Talk. Watch for updates to the recording on #youtube @RandyDAmico_MD @GautamMehtaMD @jasonpsheehan @JNeurooncol @SalimSiddiquiMD @JimSnyderDO @NBTStweets

[Jim Snyder @JimSnyderDO]

I am proud to be a part of this #research that supports additional treatment options for people with #glioma.

[Henry Ford Neuroscience @HenryFordNeuro]

This showed increased PFS in a very challenging to treat population. A great example of true multidisciplinary work done at the #HBTCStrong. @NeuroOnc @TobiasWalbertMD @JimSnyderDO @SalimSiddiquiMD @HenryFordRad @NBTStweets

[Jim Snyder @JimSnyderDO]

@monicabyrne13 @Lifeiskitsch tricky question. I agree seizures, from tumor or not, can cause hallucinations or bizarre behaviors. A tumor can disrupt perceptive and cognitive pathways in unexpected ways, cause antons syndrome or expressive speech issues...Neuro Drugs can cause hallucinations.

[Jim Snyder @JimSnyderDO]

@JennaLHeilman @Lifeiskitsch @HeadfortheCure @tiffnotes @HenryFordNeuro @Nestelynn_Gay @TobiasWalbertMD Thank you! Baby JJ loves seeing and hearing everyone

[Jim Snyder @JimSnyderDO]

Check out my latest publication on #RWD “Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement”

Thanks Dr ⁦@YoshieUmemura⁩ for the invitation and thank you to my exceptional collaborators! https://t.co/EK4oZIFpLy

[Jim Snyder @JimSnyderDO]

@Lifeiskitsch Thanks!!!! @Lifeiskitsch

[Jim Snyder @JimSnyderDO]

@TheLizArmy @HenryFordNews @NeuroOnc @NBTStweets @Lifeiskitsch @TheLizArmy So awesome to see you! Can’t wait to for your presentation tomorrow—I’m sure it will be a hit. Thanks for the kind words. You’re right, @Lifeiskitsch we need to share our experience with the #PCHETA advocacy effort.